The vaccine could revolutionize melanoma treatment, offering a personalized approach to cancer care. If successful, it may improve survival rates and reduce recurrence risks. However, the treatment is still under investigation, and its long-term efficacy and safety need further validation. Some patients experienced mild to moderate side effects, with a few requiring treatment adjustments.